[1]陕西省老年学和老年医学会风湿免疫与慢病管理分会,陕西省风湿免疫专科联盟.陕西省类风湿关节炎早期诊疗基层管理专家共识[J].陕西医学杂志,2026,(6):723-730.[doi:DOI:10.3969/j.issn.1000-7377.2026.06.001]
　The Rheumatology & Immunology and Chronic Disease Management Branch of the Shaanxi Association of Gerontology and Geriatrics,Shaanxi Rheumatology and Immunology Alliance.Expert consensus on early diagnosis and treatment management of rheumatoid arthritis at the primary level in Shaanxi Province[J].,2026,(6):723-730.[doi:DOI:10.3969/j.issn.1000-7377.2026.06.001]
点击复制

陕西省类风湿关节炎早期诊疗基层管理专家共识

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2026年6期
页码:
723-730
栏目:
专家共识
出版日期:
2026-06-05

文章信息/Info

Title:
Expert consensus on early diagnosis and treatment management of rheumatoid arthritis at the primary level in Shaanxi Province
作者:
陕西省老年学和老年医学会风湿免疫与慢病管理分会; 陕西省风湿免疫专科联盟
陕西省老年学和老年医学会风湿免疫与慢病管理分会，陕西省风湿免疫专科联盟
Author(s):
The Rheumatology & Immunology and Chronic Disease Management Branch of the Shaanxi Association of Gerontology and Geriatrics; Shaanxi Rheumatology and Immunology Alliance
The Rheumatology & Immunology and Chronic Disease Management Branch of the Shaanxi Association of Gerontology and Geriatrics，Shaanxi Rheumatology and Immunology Alliance
关键词:
类风湿关节炎; 筛查; 治疗; 长期管理; 预后; 规范; 专家共识
Keywords:
Rheumatoid arthritis; Screening; Treatment; Long-term management; Prognosis; Standardization; Expert consensus
分类号:
R 593.22
DOI:
DOI:10.3969/j.issn.1000-7377.2026.06.001
文献标志码:
A
摘要:
类风湿关节炎（RA）是一种自身免疫性、系统性的慢性炎症性疾病，致残风险随病程延长而明显增加。因此，RA的早期筛查、及时治疗和长期管理对于改善患者预后至关重要。为进一步规范培训基层RA诊疗流程，提升陕西省RA早期诊疗效能，并提高患者治疗依从性与整体预后，陕西省风湿免疫专科联盟联合陕西省老年学和老年医学会风湿与慢病管理分会，共同组建共识专家组和循证医学专家组。依据德尔菲法，专家组制定了陕西省RA早期诊疗基层管理专家共识，该共识涵盖RA筛查、诊断、治疗及患者教育等领域，共形成15条推荐意见。
Abstract:
Rheumatoid arthritis (RA) is an autoimmune and systemic chronic inflammatory disease，and the risk of disability increases significantly with the prolongation of the disease course.Therefore，early screening，timely treatment，and long-term management of RA are crucial for improving the prognosis of patients.To further standardize the training of RA diagnosis and treatment procedures at the grassroots level，enhance the early diagnosis efficiency of RA in Shaanxi Province，and improve patients’ treatment compliance and overall prognosis，the Shaanxi Rheumatology and Immunology Specialty Alliance jointly with the Rheumatology and Chronic Disease Management Subsection of the Shaanxi Geriatrics and Geriatric Medicine Association have jointly established a consensus expert group and an evidence-based medicine expert group.Based on the Delphi method，we have formulated the expert consensus on the grassroots management of early RA diagnosis and treatment in Shaanxi Province.This formula covers areas such as RA screening，diagnosis，treatment，and patient education，and has resulted in 15 recommendations.

参考文献/References:

[1]谢志军，曹炜，黄琳，等.类风湿关节炎前状态诊疗专家共识[J].中华中医药杂志，2024，39(2)：839-846.[2]北京协和医院国家皮肤与免疫疾病临床医学研究中心，中国医师协会风湿免疫专科医师分会，中国康复医学会风湿免疫病康复专业委员会，等.2024中国类风湿关节炎诊疗指南[J].中华内科杂志，2024，63(11)：1059-1077.[3]COMBE B，LANDEWE R，DAIEN C I，et al.2016 update of the EULAR recommendations for the management of early arthritis[J].Ann Rheum Dis，2017，76(6)：948-959.[4]ALETAHA D，NEOGI T，SILMAN A J，et al.2010 rheumatoid arthritis classification criteria：An American College of Rheumatology/European League Against Rheumatism collaborative initiative[J].Ann Rheum Dis，2010，69(9)：1580-1588.[5]VAN STEENBERGEN H W，ALETAHA D，BEAART-VAN DE VOORDE L J J，et al.EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis[J].Ann Rheum Dis，2017，76(3)：491-496.[6]VAN STEENBERGEN H W，DOORNKAMP F，ALIVERNINI S，et al.EULAR/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia[J].Ann Rheum Dis，2025，84(9)：1445-1457.[7]VAN STEENBERGEN H W，VAN NIES J A B，HUIZINGA T W J，et al.Characterising arthralgia in the preclinical phase of rheumatoid arthritis using MRI[J].Ann Rheum Dis，2015，74(6)：1225-1232.[8]DEN HOLLANDER N K，VERSTAPPEN M，VAN DIJK B T，et al.Disentangling heterogeneity in contemporary undifferentiated arthritis-A large cohort study using latent class analysis[J].Semin Arthritis Rheum，2023，63：152251.[9]SIDHU N，WOUTERS F，NIEMANTSVERDRIET E，et al.MRI-detected synovitis of the small joints predicts rheumatoid arthritis development in large joint undifferentiated inflammatory arthritis[J].Rheumatology (Oxford，England)，2022，61(SI)：SI23-SI29.[10]HECHT C，ENGLBRECHT M，RECH J，et al.Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA[J].Ann Rheum Dis，2015，74(12)：2151-2156.[11]VAN STEENBERGEN H W，AJEGANOVA S，FORSLIND K，et al.The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis[J].Ann Rheum Dis，2015，74(1)：e3.[12]SMOLEN J S，BREEDVELD F C，BURMESTER G R，et al.Treating rheumatoid arthritis to target：2014 update of the recommendations of an international task force[J].Ann Rheum Dis，2016，75(1)：3-15.[13]BRINKMANN G H，NORLI E S，KVIEN T K，et al.Disease characteristics and rheumatoid arthritis development in patients with early undifferentiated arthritis：A 2-year followup study[J].J Rheumatol，2017，44(2)：154-161.[14]BAKER J F，CONAGHAN P G，EMERY P，et al.Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis[J].Ann Rheum Dis，2016，75(6)：1114-1119.[15]VANIER A，SMOLEN J S，ALLAART C F，et al.An updated matrix to predict rapid radiographic progression of early rheumatoid arthritis patients：Pooled analyses from several databases[J].Rheumatology (Oxford，England)，2020，59(8)：1842-1852.[16]D’AGOSTINO M A，TERSLEV L，WAKEFIELD R，et al.Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis：From diagnosis to remission[J].Ann Rheum Dis，2016，75(11)：1902-1908.[17]SIDDLE H J，MANDL P，ALETAHA D，et al.The EULAR points to consider for health professionals undertaking musculoskeletal ultrasound for rheumatic and musculoskeletal diseases[J].Ann Rheum Dis，2018，77(2)：311-313.[18]EMERY P，VAN DER HEIJDE D，OSTERGAARD M，et al.Exploratory analyses of the association of MRI with clinical，laboratory and radiographic findings in patients with rheumatoid arthritis[J].Ann Rheum Dis，2011，70(12)：2126-2130.[19]封小川，李利霞.肌肉骨骼超声检查在跖趾类风湿关节炎与痛风性关节炎骨侵蚀鉴别诊断中的临床意义[J].陕西医学杂志，2021，50(7)：833-835.[20]DEJACO C，SINGH Y P，PEREL P，et al.2015 recommendations for the management of polymyalgia rheumatica：A European League Against Rheumatism/American College of Rheumatology collaborative initiative[J].Ann Rheum Dis，2015，74(10)：1799-1807.[21]MATTHIJSSEN X M E，WOUTERS F，SIDHU N，et al.Tenosynovitis has a high sensitivity for early ACPA-positive and ACPA-negative RA：A large cross-sectional MRI study[J].Ann Rheum Dis，2021，80(8)：974-980.[22]FINZEL S，ENGLBRECHT M，ENGELKE K，et al.A comparative study of periarticular bone lesions in rheumatoid arthritis and psoriatic arthritis[J].Ann Rheum Dis，2011，70(1)：122-127.[23]HYLDGAARD C，HILBERG O，PEDERSEN A B，et al.A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease：Comorbidity and mortality[J].Ann Rheum Dis，2017，76(10)：1700-1706.[24]FARQUHAR H J，BECKERT N，BECKERT L，et al.Survival of adults with rheumatoid arthritis associated interstitial lung disease-A systematic review and meta-analysis[J].Semin Arthritis Rheum，2023，60：152187.[25]OLSON A L，SWIGRIS J J，SPRUNGER D B，et al.Rheumatoid arthritis-interstitial lung disease-associated mortality[J].Am J Resp Crit Care，2011，183(3)：372-378.[26]SPARKS J A，DIEUD P，HOFFMANN-VOLD A，et al.Design of ANCHOR-RA：A multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis[J].BMC rheumatology，2024，8(1)：19.[27]JOHNSON S R，BERNSTEIN E J，BOLSTER M B，et al.2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases[J].Arthritis Rheumatol (Hoboken，N.J.)，2024，76(8)：1201-1213.[28]JUGE P，GRANGER B，DEBRAY M，et al.A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease[J].Arthritis Rheumatol (Hoboken，N.J.)，2022，74(11)：1755-1765.[29]MCDERMOTT G C，GILL R，BYRNE S，et al.Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies：Baseline results of SAIL-RA[J].medRxiv，2025：2021-2025.[30]BAKKER M F，JACOBS J W，WELSING P M，et al.Early clinical response to treatment predicts 5-year outcome in RA patients：Follow-up results from the CAMERA study[J].Ann Rheum Dis，2011，70(6)：1099-1103.[31]GRIGOR C，CAPELL H，STIRLING A，et al.Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study)：A single-blind randomised controlled trial[J].Lancet (London，England)，2004，364(9430)：263-269.[32]WEI Q，WANG H，ZHAO J，et al.Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis：Systematic review and network meta-analysis[J].Front Pharmacol，2023，14：1237234.[33]YTTERBERG S R，BHATT D L，MIKULS T R，et al.Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis[J].N Engl J Med，2022，386(4)：316-326.[34]POPA C D，OPDAM M A A，DEN BROEDER N，et al.Therapy with JAK inhibitors or bDMARDs and the risk of cardiovascular events in the Dutch rheumatoid arthritis population[J].Rheumatology (Oxford，England)，2024，63(8)：2142-2146.[35]EMERY P，HORTON S，DUMITRU R B，et al.Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA：The VEDERA trial[J].Ann Rheum Dis，2020，79(4)：464-471.[36]WASKO M C M，DASGUPTA A，HUBERT H，et al.Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis[J].Arthritis Rheum，2013，65(2)：334-342.[37]王小蕊，李文倩，解友邦，等.托法替尼联合传统DMARDs类药物治疗类风湿性关节炎临床效果观察[J].陕西医学杂志，2023，52(12)：1727-1730.[38]BARADAT C，DEGBO Y，CONSTANTIN A，et al.No impact of concomitant methotrexate use on serious adverse event and serious infection risk in patients with rheumatoid arthritis treated with bDMARDs：A systematic literature review and meta-analysis[J].RMD Open，2017，3(1)：e352.[39]BOLETO G A，KANAGARATNAM L，DRAM M，et al.Safety of combination therapy with two bDMARDs in patients with rheumatoid arthritis：A systematic review and meta-analysis[J].Semin Arthritis Rheum，2019，49(1)：35-42.[40]TEMMOKU J，MIGITA K，YOSHIDA S，et al.Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis[J].Medicine，2022，101(42)：e31161.

相似文献/References:

[1]蒋洪波,杨龙涛,周红荣△.三种方法在子宫颈癌及癌前病变筛查中的价值比较[J].陕西医学杂志,2019,(2):217.
　JIANG Hongbo,YANG Longtao,ZHOU Hongrong..Comparison of diagnostic value of three kinds of screening methods in cervical cancer and precancerous lesions[J].,2019,(6):217.
[2]卢北玲,史剑飞,彭 晶,等.CRP、RF及ASO检测在类风湿关节炎合并肺间质纤维化诊断中的价值[J].陕西医学杂志,2019,(6):803.
[3]孙芳芳,张 静△,范秀风.类风湿关节炎合并心血管损伤危险因素研究*[J].陕西医学杂志,2019,(10):1305.
[4]王 颖,白 琳,张 洁,等.抑制炎性细胞因子与类风湿关节炎合并急性心肌梗死患者颈动脉斑块相关性研究*[J].陕西医学杂志,2019,(12):1679.
[5]刘昌莲,贺冬冬,李晓明,等.艾拉莫德治疗类风湿关节炎疗效及对患者免疫炎症因子水平和骨代谢指标的影响*[J].陕西医学杂志,2020,49(5):603.
　LIU Changlian,HE Dongdong,LI Xiaoming,et al.Clinical efficacy of Iguratimod in the treatment of rheumatoid arthritis and its effect on the levels of immune inflammatory factors and the indexes of bone metabolism[J].,2020,49(6):603.
[6]刘兆宜,沈洲立,岳跃兵,等.类风湿关节炎并发动脉粥样硬化相关性研究进展*[J].陕西医学杂志,2020,49(11):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
　LIU Zhaoyi,SHEN Zhouli,YUE Yuebing,et al.Research progress on the correlation between rheumatoid arthritis and atherosclerosis[J].,2020,49(6):1534.[doi:DOI:10.3969/j.issn.1000-7377.2020.11.043]
[7]李长超,柴艳梅,刘 丹,等.类风湿关节炎患者血清IL-13水平表达及对外周血单个核细胞中Th17细胞亚群分化的影响[J].陕西医学杂志,2021,50(2):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
　LI Changchao,CHAI Yanmei,LIU Dan,et al.Expression of serum IL-13 in patients with rheumatoid arthritis and its effect on differentiation of Th17 cell subsets in PBMC[J].,2021,50(6):197.[doi:DOI:10.3969/j.issn.1000-7377.2021.02.018]
[8]安 新,冯 超,高利常.类风湿关节炎患者血清白细胞介素-32、白细胞介素-17和白细胞介素-10表达水平及临床意义[J].陕西医学杂志,2021,50(12):1585.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.030]
　AN Xin,FENG Chao,GAO Lichang.Expression levels of serum interleukin-32,interleukin-17 and interleukin-10 in patients with rheumatoid arthritis and their clinical significance[J].,2021,50(6):1585.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.030]
[9]杨 婧,何家锐,孙红兵,等.沙利度胺对类风湿关节炎滑膜细胞及外周血单个核细胞分泌肿瘤坏死因子-α和血管内皮生长因子的影响及机制研究[J].陕西医学杂志,2022,51(12):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]
　YANG Jing,HE Jiarui,SUN Hongbing,et al.Effects of thalidomide on secretion of TNF-α and VEGF in fibroblast-like synoviocytes and peripheral blood mononuclear cells in patients with rheumatoid arthritis and its mechanism[J].,2022,51(6):1501.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.008]
[10]王小蕊,李文倩,解友邦,等.托法替尼联合传统DMARDs类药物治疗类风湿性关节炎临床效果观察[J].陕西医学杂志,2023,52(12):1728.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.022]
　WANG Xiaorui,LI Wenqian,XIE Youbang,et al.Clinical effect of tofacitinib combined with traditional DMARDs in treatment of rheumatoid arthritis[J].,2023,52(6):1728.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.022]

备注/Memo

备注/Memo:
陕西省重点研发计划项目（2023-ZDLSF-41）
更新日期/Last Update: 2026-06-05